Autoinjector Market Research 2022-2027

1
Global Autoinjector Market Research and Forecast
Report 2022-2027




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Autoinjector Market Research
Report According to the latest report by IMARC
Group, titled Autoinjector Market Global
Industry Trends, Share, Size, Growth, Opportunity
and Forecast 2022-2027 the global autoinjector
market reached a strong growth in
2021.  Autoinjectors refer to self-injectable
medical devices used to administer drugs and
antidotes through the subcutaneous or
intramuscular route. They comprise spring-loaded
prefilled syringes or cartridges that deliver a
calculated dose of medication upon being
activated. They facilitate easy
self-administration, enhance patient compliance,
lower anxiety, and ensure dosage accuracy. They
also help reduce needle phobia of patients,
minimize needlestick injuries caused by hidden
needles, and improve the efficiency of healthcare
professionals. As a result, autoinjectors are
widely utilized for rapid and safe drug
administration during emergency conditions,
including diabetes, multiple sclerosis (MS),
migraine, seizures, psoriasis, and rheumatoid
arthritis. Request Free Sample Report
https//www.imarcgroup.com/autoinjector-market/req
uestsample
4
Report Description and Highlights
Report Description

Global Autoinjector Market Trends The global
autoinjector market is primarily driven by the
increasing incidences of chronic and lifestyle
diseases and the escalating demand for enhanced
patient convenience. Additionally, individuals
are rapidly shifting from conventional devices
toward self-administrating devices, such as
autoinjectors, due to the growing awareness
regarding their benefits. In line with this,
several favorable initiatives undertaken by
governments of various countries to promote the
usage of autoinjectors in schools for first-aid
treatment during emergencies have augmented the
product demand. Furthermore, the leading players
are launching innovative, simple, and
cost-effective autoinjectors based on advanced
technologies for treating relapsing-remitting MS
and other conditions, thereby propelling the
market growth. Other factors, including the
expanding healthcare industry, aging population,
rising product approvals, surging adoption of
targeted therapies, growing inclination toward
homecare therapeutics, and ongoing research and
development (RD) activities, are also
anticipated to drive the market further. Looking
forward, the market value is projected to reach a
strong growth during the forecast period
(2022-2027).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Type Disposable Au
toinjectors Reusable Autoinjectors Breakup b
y Application Rheumatoid Arthritis Anaphyla
xis Multiple Sclerosis Others Breakup by E
nd User

6
Report Description and Highlights
Report Description
Home Care Settings Hospitals and Clinics Bre
akup by Region North America
United States Canada
Asia Pacific China
Japan India
South Korea Australia
Indonesia Othe
rs Europe Germany
France United King
dom

7
Report Description and Highlights
Report Description
Italy Spain
Russia Others
Latin America Brazil
Mexico Others
Middle East and Africa Note We are updati
ng our reports, If you want latest primary and
secondary data (2022-2027) with Cost Module,
Business Strategy, Distribution Channel, etc.
Click request free sample report.

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Antares Pharma Inc. Becton Dickinson and Company B
  ristol-Myers Squibb Company Eisai Co. Ltd. Eli Lil
  ly and Company Haselmeier GmbH (Sulzer Ltd.) Johns
  on Johnson Mylan N.V. (Viatris Inc.) Novartis AG
  SHL Medical AG Teva Pharmaceutical Industries
  Ltd. Ypsomed Holding AG.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/autoinjector-market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us